Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1991-09-13
1993-05-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424490, 424497, 514356, A61K 916
Patent
active
052099334
ABSTRACT:
There is disclosed an improved long acting sustained release pharmaceutical composition for dihydropyridine calcium channel blockers wherein the calcium channel blocker and a pH-dependent binder, which are intimately admixed in essentially spherically shaped non-rugose particles of up to 1.2 mm in diameter, are provided with a coating to obtain slow, sustained release of a safe, therapeutically effective amount of the calcium channel blocker over a period of at least about 24 hours. Thus, the improved pharmaceutical composition for a dihydropyridine calcium channel blockers is suitable for once daily administration.
REFERENCES:
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4665100 (1987-05-01), Ludwig
patent: 4704295 (1987-11-01), Porter
patent: 4758437 (1988-07-01), Sonobe
patent: 4765990 (1988-08-01), Sugimoto et al.
patent: 4816264 (1989-03-01), Phillips
patent: 4857312 (1989-08-01), Hegasy
patent: 4859665 (1989-08-01), Garthoff
patent: 4940556 (1990-07-01), MacFarlane
patent: 4970081 (1990-11-01), Frisbee
Dey Michael J.
Langridge John R.
MacFarlane Calum B.
Selkirk Alastair B.
Lowin David A.
Moran Tom M.
Page Thurman K.
Phelan D. Gabrielle
Syntex (U.S.A.) Inc.
LandOfFree
Long acting calcium channel blocker composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long acting calcium channel blocker composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting calcium channel blocker composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1348900